Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX versus placebo for neurogenic detrusor overactivity in patients with neurological respiratory impairment
2006-006299-39Phase 3Terminated
- Sponsor
- Allergan
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A in detrusor hyperreflexia (DH) and urinary incontinence (UI) (3 arms), sponsored by Allergan. Primary endpoint: Number of episodes of urinary incontinence. Started Jun 2007; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)urinary incontinence (UI)
Beyond the preview
Go deeper on 2006-006299-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006299-39.